(NASDAQ: KMTS) Kestra Medical Technologies's forecast annual revenue growth rate of 31.42% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.63%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.99%.
Kestra Medical Technologies's revenue in 2026 is $83,721,000.On average, 9 Wall Street analysts forecast KMTS's revenue for 2026 to be $5,535,545,065, with the lowest KMTS revenue forecast at $5,311,216,269, and the highest KMTS revenue forecast at $5,706,287,123. On average, 9 Wall Street analysts forecast KMTS's revenue for 2027 to be $7,912,507,999, with the lowest KMTS revenue forecast at $7,324,104,601, and the highest KMTS revenue forecast at $8,323,456,404.
In 2028, KMTS is forecast to generate $11,299,913,674 in revenue, with the lowest revenue forecast at $10,766,381,227 and the highest revenue forecast at $11,848,039,458.